Randomized Phase II Trial of Abiraterone Alone or With Dasatinib in Men With Metastatic Castration-resistant Prostate Cancer (mCRPC)
- Resource Type
- Article
- Source
- In
Clinical Genitourinary Cancer August 2019 17(4):241-247 - Subject
- Language
- ISSN
- 1558-7673